Administration of a selective retinoic acid receptor-γ agonist improves neuromuscular strength in a rodent model of volumetric muscle loss

PURPOSE: Volumetric muscle loss is a uniquely challenging pathology that results in irrecoverable functional deficits. Furthermore, a breakthrough drug or bioactive factor has yet to be established that adequately improves repair of these severe skeletal muscle injuries. This study sought to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitely, Michael E., Collins, Patrick B., Iwamoto, Masahiro, Wenke, Joseph C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360252/
https://www.ncbi.nlm.nih.gov/pubmed/34383202
http://dx.doi.org/10.1186/s40634-021-00378-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360252/
https://www.ncbi.nlm.nih.gov/pubmed/34383202
http://dx.doi.org/10.1186/s40634-021-00378-3

Ejemplares similares